15788496

Source:http://linkedlifedata.com/resource/pubmed/id/15788496

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0055598, umls-concept:C0392752, umls-concept:C1332225, umls-concept:C1413947, umls-concept:C1522449
pubmed:issue	12
pubmed:dateCreated	2005-3-24
pubmed:abstractText	Chemoradiotherapy is standard treatment for localized aggressive lymphoma. To determine the optimal therapy for nonelderly persons with low-risk localized lymphoma, we conducted a randomized trial comparing chemoradiotherapy with chemotherapy alone.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15788496-15788502, http://linkedlifedata.com/resource/pubmed/commentcorrection/15788496-15944432, http://linkedlifedata.com/resource/pubmed/commentcorrection/15788496-15948267, http://linkedlifedata.com/resource/pubmed/commentcorrection/15788496-15948268
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/Vindesine
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1533-4406
pubmed:author	pubmed-author:BoslyAndreA, pubmed-author:BricePaulineP, pubmed-author:CoiffierBertrandB, pubmed-author:FermeChristopheC, pubmed-author:GanemGérardG, pubmed-author:Groupe d'Etude des Lymphomes de l'Adulte (GELA), pubmed-author:GuyLaurentL, pubmed-author:LederlinPierreP, pubmed-author:LepageEricE, pubmed-author:MolinaThierry JTJ, pubmed-author:MorelPierreP, pubmed-author:ReyesFélixF, pubmed-author:TillyHervéH
pubmed:copyrightInfo	Copyright 2005 Massachusetts Medical Society.
pubmed:issnType	Electronic
pubmed:day	24
pubmed:volume	352
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1197-205
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15788496-Adolescent, pubmed-meshheading:15788496-Adult, pubmed-meshheading:15788496-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15788496-Bleomycin, pubmed-meshheading:15788496-Combined Modality Therapy, pubmed-meshheading:15788496-Cyclophosphamide, pubmed-meshheading:15788496-Disease-Free Survival, pubmed-meshheading:15788496-Doxorubicin, pubmed-meshheading:15788496-Female, pubmed-meshheading:15788496-Humans, pubmed-meshheading:15788496-Lymphoma, Non-Hodgkin, pubmed-meshheading:15788496-Male, pubmed-meshheading:15788496-Middle Aged, pubmed-meshheading:15788496-Multivariate Analysis, pubmed-meshheading:15788496-Neoplasm Staging, pubmed-meshheading:15788496-Prednisone, pubmed-meshheading:15788496-Survival Analysis, pubmed-meshheading:15788496-Survival Rate, pubmed-meshheading:15788496-Treatment Outcome, pubmed-meshheading:15788496-Vincristine, pubmed-meshheading:15788496-Vindesine
pubmed:year	2005
pubmed:articleTitle	ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
pubmed:affiliation	Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France. felix.reyes@hmn.ap-hop-paris.fr
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study